OUR RESEARCH

The Philip A. Salem Chair in Cancer Research was  established with $2.5 million in philanthropic gifts. As the Director of Cancer Research at St. Luke's Episcopal Hospital, Dr. Salem presently holds the chair and upon his retirement, he will assist St. Luke's in recruiting his successor. Dr.  Salem has been the Director of Cancer Research at the Cancer Center at St. Luke's since 1992.  During this time he was responsible for the hospital actively participating in the Texas Community Oncology Network, a cooperative research program with M.D. Anderson Cancer Center.

More than 30 cancer research treatment protocols were available to St. Luke's physicians for their patients from 1992-1999. The first and second National Surgical Adjuvant Breast and Bowel historic breast cancer prevention trials were made available to St. Luke's patients from 1995-2006 through Dr. Salem's guidance and leadership.  He was the recipient of a $200,000 grant from the Dallas chapter of the American Cancer Society in 2008 to support cancer research and mentor young research investigators. His grant has funded a full time cancer research nurse for the Cancer Center at St. Luke's as well as clinical research.

St. Luke's recently opened its new Oncology Medical Clinic to provide evaluation and treatment of medical oncology and blood disorders.

Onsite services include diagnostic radiology, infusion services, radiation oncology, peripheral vascular testing and bone marrow biopsy. Under the leadership of Luis H. Camacho, MD, the Clinic will offer oncology clinical trials as additional patient options in the treatment of their disease. 

Dr. Camacho also serves as Medical Director for the Cancer Center at St. Luke's, which in 2011 was once again awarded a three-year Accreditation with Commendation from the Commission on Cancer. He is a member of the American Society of Clinical Oncology Scientific Immunotherapy committee and a member of the Special Projects Study Section of the National Cancer Institute. He serves on the CanCare Medical Advisory Board and is a member of St. Luke's Cancer Center committee and the Hematology/Oncology section. At the state level, Dr. Camacho is a Director-at-large on the Board of Directors of the Texas Society of Clinical Oncology and holds an Alternate Delegate position on the HCMS Delegation of the Harris County Medical Society.


CLINICAL TRIALS

The Cancer Center at CHI St. Luke's Health offers patients access to frontline cancer research by providing clinical trials led by physician investigators specializing in oncology. CHI St. Luke's also offers cancer control in the form of cancer screening for individuals at high risk for cancer. Investigators offer national clinical studies, as well as original hospital-based studies. Contact the Cancer Research Program Office at 832-355-7226 to inquire about any of the clinical trials below.


CANCER REGISTRY
The CHI St. Luke’s Health Cancer Registry has a database of over 37,000 diagnosed cases since the reference date of 1992 at CHI St. Luke’s.  The most current data reveal that the registry abstracted 2,407cancer cases and had a 92% follow-up rate on former cancer patients.  The Registry reports statistical data to the National Cancer Data Base and the Texas Department of Health State Cancer Registry.  The statistics are used for cancer research, to monitor survival statistics and to improve the standard of care in disease recurrence.  The Cancer Registry also organizes the 12 tumor boards per month at St. Luke’s, promoting multidisciplinary care for our cancer.

For More Information: 

Cancer Center Research Department
2457 S. Braeswood Blvd.
Houston, TX 77030
Email: ccr@stlukeshealth.org
Office: 832.355.7226
Fax: 832 355.7197